Frederic M Waldman
Overview
Explore the profile of Frederic M Waldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
4156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heng Y, Lester S, Tse G, Factor R, Allison K, Collins L, et al.
J Pathol
. 2016 Nov;
241(3):375-391.
PMID: 27861902
The histopathological evaluation of morphological features in breast tumours provides prognostic information to guide therapy. Adjunct molecular analyses provide further diagnostic, prognostic and predictive information. However, there is limited knowledge...
2.
Nikita M, Jiang W, Cheng S, Hantash F, McPhaul M, Newbury R, et al.
Thyroid
. 2015 Dec;
26(2):227-34.
PMID: 26649796
Background: Well-differentiated thyroid cancer (WDTC) incidence in pediatrics is rising, most being papillary thyroid carcinoma (PTC). The objective of the study was to assess the prevalence of different mutations in...
3.
Li Y, Bare L, Bender R, Sninsky J, Wilson L, Devlin J, et al.
Mol Diagn Ther
. 2015 May;
19(3):169-77.
PMID: 25926090
Objective: To determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes would cost-effectively aid in the treatment selection for patients with metastatic melanoma, compared with a single-site BRAF...
4.
Shin S, Lal A, De Vries S, Suzuki J, Roy R, Hwang E, et al.
Hum Pathol
. 2013 Jul;
44(10):1998-2009.
PMID: 23809857
We evaluated genomic alterations and biomarker expression in 20 florid lobular carcinomas in situ using array-based comparative genomic hybridization and immunohistochemical analysis. The genetic characteristics of florid lobular carcinoma in...
5.
Lal A, Chan L, DeVries S, Chin K, Scott G, Benz C, et al.
Breast Cancer Res Treat
. 2013 May;
139(2):381-90.
PMID: 23712790
FOXP3-expressing T regulatory lymphocytes (Tregs) have been described as putative mediators of immune tolerance, and thus facilitators of tumor growth. When found in association with various malignancies, Tregs are generally...
6.
Moore L, Nickerson M, Brennan P, Toro J, Jaeger E, Rinsky J, et al.
PLoS Genet
. 2011 Oct;
7(10):e1002312.
PMID: 22022277
Renal tumor heterogeneity studies have utilized the von Hippel-Lindau VHL gene to classify disease into molecularly defined subtypes to examine associations with etiologic risk factors and prognosis. The aim of...
7.
Hwang E, Lal A, Chen Y, DeVries S, Swain R, Anderson J, et al.
Hum Pathol
. 2011 Apr;
42(10):1467-75.
PMID: 21496874
A clinically distinct subgroup of pure ductal carcinoma in situ presents as an extensive, high-grade lesion, which nevertheless lacks invasion. We sought to evaluate differences between those ductal carcinomas in...
8.
Chen Y, Hwang E, Roy R, DeVries S, Anderson J, Wa C, et al.
Am J Surg Pathol
. 2009 Aug;
33(11):1683-94.
PMID: 19701073
The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this study, we analyzed...
9.
Chen Y, DeVries S, Anderson J, Lessing J, Swain R, Chin K, et al.
BMC Cancer
. 2009 Aug;
9:285.
PMID: 19689789
Background: Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma in situ (DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach...
10.
Mitra A, Pagliarulo V, Yang D, Waldman F, Datar R, Skinner D, et al.
J Clin Oncol
. 2009 Jul;
27(24):3929-37.
PMID: 19620494
Purpose: This study sought to determine if alterations in molecular pathways could supplement TNM staging to more accurately predict clinical outcome in patients with urothelial carcinoma (UC). Patients And Methods:...